An immunosuppressed Syrian golden hamster model for SARS-CoV infection

Scott R. Schaecher, Jennifer Stabenow, Christina Oberle, Jill Schriewer, R. Mark Buller, John E. Sagartz, Andrew Pekosz

Research output: Contribution to journalArticle

Abstract

Several small animal models have been developed for the study of severe acute respiratory syndrome coronavirus (SARS-CoV) replication and pathogenesis. Syrian golden hamsters are among the best small animal models, though little clinical illness and no mortality are observed after virus infection. Cyclophosphamide was used to immunosuppress hamsters leading to a prolonged disease course and higher mortality after SARS-CoV infection. In addition, there was a significant weight loss, expanded tissue tropism, and increased viral pathology in the lung, heart, kidney, and nasal turbinate tissues. Infection with recombinant SARS-CoV viruses bearing disruptions in the gene 7 coding region showed no significant change in replication kinetics, tissue tropism, morbidity, or mortality suggesting that the ORF7a (7a) and ORF7b (7b) proteins are not required for virus replication in immunosuppressed hamsters. This modified hamster model may provide a useful tool for SARS-CoV pathogenesis studies, evaluation of antiviral therapy, and analysis of additional SARS-CoV mutants.

Original languageEnglish (US)
Pages (from-to)312-321
Number of pages10
JournalVirology
Volume380
Issue number2
DOIs
StatePublished - Oct 25 2008

Fingerprint

Coronavirus Infections
Severe Acute Respiratory Syndrome
Coronavirus
Mesocricetus
Cricetinae
Mortality
Viral Tropism
Animal Models
SARS Virus
Turbinates
Tropism
Virus Diseases
Virus Replication
Nose
Cyclophosphamide
Antiviral Agents
Weight Loss
Pathology
Morbidity
Kidney

Keywords

  • Accessory gene
  • Coronavirus
  • Cyclophosphamide
  • Hamster
  • ORF7a
  • ORF7b
  • Pathogenesis
  • SARS-CoV

ASJC Scopus subject areas

  • Virology

Cite this

Schaecher, S. R., Stabenow, J., Oberle, C., Schriewer, J., Buller, R. M., Sagartz, J. E., & Pekosz, A. (2008). An immunosuppressed Syrian golden hamster model for SARS-CoV infection. Virology, 380(2), 312-321. https://doi.org/10.1016/j.virol.2008.07.026

An immunosuppressed Syrian golden hamster model for SARS-CoV infection. / Schaecher, Scott R.; Stabenow, Jennifer; Oberle, Christina; Schriewer, Jill; Buller, R. Mark; Sagartz, John E.; Pekosz, Andrew.

In: Virology, Vol. 380, No. 2, 25.10.2008, p. 312-321.

Research output: Contribution to journalArticle

Schaecher, SR, Stabenow, J, Oberle, C, Schriewer, J, Buller, RM, Sagartz, JE & Pekosz, A 2008, 'An immunosuppressed Syrian golden hamster model for SARS-CoV infection', Virology, vol. 380, no. 2, pp. 312-321. https://doi.org/10.1016/j.virol.2008.07.026
Schaecher SR, Stabenow J, Oberle C, Schriewer J, Buller RM, Sagartz JE et al. An immunosuppressed Syrian golden hamster model for SARS-CoV infection. Virology. 2008 Oct 25;380(2):312-321. https://doi.org/10.1016/j.virol.2008.07.026
Schaecher, Scott R. ; Stabenow, Jennifer ; Oberle, Christina ; Schriewer, Jill ; Buller, R. Mark ; Sagartz, John E. ; Pekosz, Andrew. / An immunosuppressed Syrian golden hamster model for SARS-CoV infection. In: Virology. 2008 ; Vol. 380, No. 2. pp. 312-321.
@article{cc9eaf35ce1e44e8afca2e51947c0cda,
title = "An immunosuppressed Syrian golden hamster model for SARS-CoV infection",
abstract = "Several small animal models have been developed for the study of severe acute respiratory syndrome coronavirus (SARS-CoV) replication and pathogenesis. Syrian golden hamsters are among the best small animal models, though little clinical illness and no mortality are observed after virus infection. Cyclophosphamide was used to immunosuppress hamsters leading to a prolonged disease course and higher mortality after SARS-CoV infection. In addition, there was a significant weight loss, expanded tissue tropism, and increased viral pathology in the lung, heart, kidney, and nasal turbinate tissues. Infection with recombinant SARS-CoV viruses bearing disruptions in the gene 7 coding region showed no significant change in replication kinetics, tissue tropism, morbidity, or mortality suggesting that the ORF7a (7a) and ORF7b (7b) proteins are not required for virus replication in immunosuppressed hamsters. This modified hamster model may provide a useful tool for SARS-CoV pathogenesis studies, evaluation of antiviral therapy, and analysis of additional SARS-CoV mutants.",
keywords = "Accessory gene, Coronavirus, Cyclophosphamide, Hamster, ORF7a, ORF7b, Pathogenesis, SARS-CoV",
author = "Schaecher, {Scott R.} and Jennifer Stabenow and Christina Oberle and Jill Schriewer and Buller, {R. Mark} and Sagartz, {John E.} and Andrew Pekosz",
year = "2008",
month = "10",
day = "25",
doi = "10.1016/j.virol.2008.07.026",
language = "English (US)",
volume = "380",
pages = "312--321",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - An immunosuppressed Syrian golden hamster model for SARS-CoV infection

AU - Schaecher, Scott R.

AU - Stabenow, Jennifer

AU - Oberle, Christina

AU - Schriewer, Jill

AU - Buller, R. Mark

AU - Sagartz, John E.

AU - Pekosz, Andrew

PY - 2008/10/25

Y1 - 2008/10/25

N2 - Several small animal models have been developed for the study of severe acute respiratory syndrome coronavirus (SARS-CoV) replication and pathogenesis. Syrian golden hamsters are among the best small animal models, though little clinical illness and no mortality are observed after virus infection. Cyclophosphamide was used to immunosuppress hamsters leading to a prolonged disease course and higher mortality after SARS-CoV infection. In addition, there was a significant weight loss, expanded tissue tropism, and increased viral pathology in the lung, heart, kidney, and nasal turbinate tissues. Infection with recombinant SARS-CoV viruses bearing disruptions in the gene 7 coding region showed no significant change in replication kinetics, tissue tropism, morbidity, or mortality suggesting that the ORF7a (7a) and ORF7b (7b) proteins are not required for virus replication in immunosuppressed hamsters. This modified hamster model may provide a useful tool for SARS-CoV pathogenesis studies, evaluation of antiviral therapy, and analysis of additional SARS-CoV mutants.

AB - Several small animal models have been developed for the study of severe acute respiratory syndrome coronavirus (SARS-CoV) replication and pathogenesis. Syrian golden hamsters are among the best small animal models, though little clinical illness and no mortality are observed after virus infection. Cyclophosphamide was used to immunosuppress hamsters leading to a prolonged disease course and higher mortality after SARS-CoV infection. In addition, there was a significant weight loss, expanded tissue tropism, and increased viral pathology in the lung, heart, kidney, and nasal turbinate tissues. Infection with recombinant SARS-CoV viruses bearing disruptions in the gene 7 coding region showed no significant change in replication kinetics, tissue tropism, morbidity, or mortality suggesting that the ORF7a (7a) and ORF7b (7b) proteins are not required for virus replication in immunosuppressed hamsters. This modified hamster model may provide a useful tool for SARS-CoV pathogenesis studies, evaluation of antiviral therapy, and analysis of additional SARS-CoV mutants.

KW - Accessory gene

KW - Coronavirus

KW - Cyclophosphamide

KW - Hamster

KW - ORF7a

KW - ORF7b

KW - Pathogenesis

KW - SARS-CoV

UR - http://www.scopus.com/inward/record.url?scp=53249121018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53249121018&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2008.07.026

DO - 10.1016/j.virol.2008.07.026

M3 - Article

C2 - 18760437

AN - SCOPUS:53249121018

VL - 380

SP - 312

EP - 321

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -